Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
ResearchHow psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
ResearchHow engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.
ResearchA clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
ResearchHow Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
ResearchA strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
ResearchAI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
ResearchZosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.
ResearchAlzheimer’s drug pipelines are evolving as amyloid antibodies, oral agents, and precision trials redefine disease-modifying strategies.
ResearchExplore how CCS strengthens sterility, reduces deviations, and drives proactive contamination control in pharma.
ResearchFlow chemistry and smart delivery systems are redefining drug design, precision dosing, and personalized medicine.
ResearchDiscover DSIP’s neuroprotective, stress-adaptive, and mitochondrial roles in research.
ResearchLearn TXA2’s role in disease and how TXA2 rat ELISA kits track its activity in heart, lung, kidney, and brain research.